Aquestive COO exercises warrant for 4,587 shares
Aquestive Therapeutics’ COO exercised a warrant for 4,587 shares at $0.96, ending the warrant and bringing her holdings to 206,833 shares directly plus 2,000 held by her spouse.
Rhea-AI Filing Summary
Aquestive Therapeutics, Inc. (AQST) reported that Chief Operating Officer Cassie Jung exercised a warrant to acquire 4,587 shares of Common Stock on September 3, 2026 by paying an exercise price of $0.96 per share, in a transaction not reported as made under a Rule 10b5-1 plan.
The related warrant, originally issued on June 8, 2022 under a Securities Purchase Agreement dated June 6, 2022, became exercisable on December 8, 2022 and expires on June 8, 2027, and now reflects 0 warrants remaining after the exercise. Following this transaction, Jung holds 206,833 shares of Common Stock directly and 2,000 shares indirectly through her spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
4,587 shares exercised/converted
Exercise
3 txns
Insider
Jung Cassie
Role
Chief Operating Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| In-the-Money Exercise | Warrant (Right to Buy) | 4,587 | $0.00 | $0.00 |
| In-the-Money Exercise | Common Stock F1 | 4,587 | $0.96 | $4K |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Warrant (Right to Buy) — 0 contracts (Direct);
Common Stock — 206,833 shares (Direct);
Common Stock — 2,000 shares (Indirect, by spouse)
Footnotes (1)
- F1. Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022. The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share.
Key Figures
Shares acquired via warrant exercise: 4,587 shares of Common Stock
Exercise price: $0.96 per share
Direct Common Stock holdings after transaction: 206,833 shares
+3 more
6 metrics
Shares acquired via warrant exercise
4,587 shares of Common Stock
Exercised on September 3, 2026 from a Common Stock Purchase Warrant
Exercise price
$0.96 per share
Cash exercise of Common Stock Purchase Warrant covering 4,587 shares
Direct Common Stock holdings after transaction
206,833 shares
Direct ownership by COO Cassie Jung following the September 3, 2026 exercise
Indirect Common Stock holdings after transaction
2,000 shares
Held indirectly by spouse after the reported transactions
Warrants remaining after exercise
0 warrants
Balance of the exercised Common Stock Purchase Warrant as of September 3, 2026
Warrant expiration date
June 8, 2027
Expiration date of the Common Stock Purchase Warrant that was exercised
Key Terms
Common Stock Purchase Warrant, Securities Purchase Agreement, exercise price
3 terms
Common Stock Purchase Warrant financial
"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022."
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
Securities Purchase Agreement financial
"Represents the exercise for cash of a Common Stock Purchase Warrant issued to the Reporting Person on June 8, 2022 pursuant to a Securities Purchase Agreement dated June 6, 2022."
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
exercise price financial
"The warrant became exercisable on December 8, 2022, expires on June 8, 2027, and has an exercise price of $0.96 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What transaction did Aquestive Therapeutics (AQST) report for COO Cassie Jung on September 3, 2026?
COO Cassie Jung exercised a warrant to acquire 4,587 shares of Common Stock on September 3, 2026 at an exercise price of $0.96 per share, in a cash exercise of a Common Stock Purchase Warrant originally issued in June 2022.
What happened to the warrant exercised by the Aquestive Therapeutics (AQST) COO?
The Common Stock Purchase Warrant covering 4,587 shares, with an exercise price of $0.96 per share, was fully exercised for cash, leaving 0 warrants of that series held by the reporting person after the transaction.
What were the key terms of the warrant exercised in the AQST Form 4 filing?
The warrant exercised by the COO was issued on June 8, 2022 under a Securities Purchase Agreement dated June 6, 2022, became exercisable on December 8, 2022, expires on June 8, 2027, and had an exercise price of $0.96 per share.
Was the September 3, 2026 AQST insider transaction made under a Rule 10b5-1 trading plan?
No. The Form 4 indicates that the transactions reported for September 3, 2026 were not reported as being made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
